Cemiplimab

Immunoglobulin G4, anti-(human programmed cell death protein 1) (human monoclonal REGN2810 heavy chain), disulfide with human monoclonal REGN2810 kappa-chain, dimer

Stoffgruppe

Antineoplastisches Mittel (Checkpoint-Inhibitor)